WORCESTER, Mass., Aug. 18, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a sales agreement with McCarthy and Sons Service (http://www.rafter8.ca/mccarthy-sons-service), a leading Canadian sales firm to veterinarians, pursuant to which McCarthy and Sons will promote sales of Glucose RapidSpray(tm) (www.glucoserapidspray.com), the Company’s proprietary glucose spray product, on an exclusive representation basis to veterinarian clinics and veterinarian hospitals in the animal health industry in Canada.
